PERSANO, MARA
 Distribuzione geografica
Continente #
EU - Europa 629
AS - Asia 443
NA - Nord America 419
AF - Africa 30
OC - Oceania 17
SA - Sud America 14
Totale 1.552
Nazione #
IT - Italia 410
US - Stati Uniti d'America 402
CN - Cina 258
DE - Germania 73
IN - India 46
GB - Regno Unito 42
JP - Giappone 30
HK - Hong Kong 15
TW - Taiwan 15
AU - Australia 14
BE - Belgio 13
CA - Canada 13
KR - Corea 12
PH - Filippine 12
TR - Turchia 12
EG - Egitto 11
FR - Francia 11
NL - Olanda 10
SE - Svezia 8
ID - Indonesia 7
IE - Irlanda 7
PT - Portogallo 7
SG - Singapore 6
UA - Ucraina 6
AT - Austria 5
BR - Brasile 5
CH - Svizzera 5
ES - Italia 5
PL - Polonia 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
BD - Bangladesh 4
DZ - Algeria 4
RO - Romania 4
UG - Uganda 4
ZA - Sudafrica 4
FI - Finlandia 3
GR - Grecia 3
IR - Iran 3
LT - Lituania 3
MK - Macedonia 3
MX - Messico 3
NZ - Nuova Zelanda 3
PE - Perù 3
VN - Vietnam 3
AR - Argentina 2
CO - Colombia 2
IL - Israele 2
MA - Marocco 2
MN - Mongolia 2
PK - Pakistan 2
RU - Federazione Russa 2
TG - Togo 2
AL - Albania 1
BF - Burkina Faso 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CL - Cile 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
IQ - Iraq 1
JM - Giamaica 1
LU - Lussemburgo 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
SA - Arabia Saudita 1
SN - Senegal 1
Totale 1.552
Città #
Cagliari 249
Shanghai 54
Beijing 44
Ashburn 38
Houston 32
Santa Cruz 24
Johnson City 23
Milan 23
Rome 21
Fairfield 17
Tokyo 16
New York 14
Guangzhou 13
Seattle 13
Hangzhou 11
Nanjing 11
Brussels 9
San Diego 9
Ann Arbor 8
Changchun 8
Istanbul 8
Cairo 7
Cambridge 7
Mumbai 7
Chengdu 6
Dublin 6
Guiyang 6
London 6
Los Angeles 6
Munich 6
Naples 6
Turin 6
Wilmington 6
Baltimore 5
Bengaluru 5
Changsha 5
Chicago 5
Fremont 5
Harwich 5
Heidelberg 5
Jinan 5
Sydney 5
Woodbridge 5
Bisceglie 4
Boardman 4
Central 4
Chongqing 4
Greenbelt 4
Hat Yai 4
Las Vegas 4
Linz 4
Redmond 4
Sambuca di Sicilia 4
San Francisco 4
San Vendemiano 4
Shenyang 4
Wuhan 4
Amadora 3
Cagayan de Oro 3
Central District 3
Chennai 3
Chittagong 3
Coimbatore 3
Delhi 3
Frankfurt am Main 3
Gurgaon 3
Helsinki 3
Lexington 3
Lima 3
Lucknow 3
New Delhi 3
Nishinotoindori 3
Osaka 3
Perugia 3
Phoenix 3
Salerno 3
Shenzhen 3
Stein 3
Taipei 3
Toronto 3
Washington 3
Xian 3
Amsterdam 2
Antwerpen 2
Aurora 2
Bad Hersfeld 2
Bari 2
Berlin 2
Bolton 2
Brooklyn 2
Buffalo 2
Cascina 2
Castagnole delle Lanze 2
Castellammare di Stabia 2
Charlottesville 2
Cleveland 2
Dalian 2
Darmstadt 2
Dong Ket 2
Edolo 2
Totale 937
Nome #
New therapeutic targets in pancreatic cancer, file e2f56ed8-ef81-3eaf-e053-3a05fe0a5d97 1.027
Molecular-biology-driven treatment for metastatic colorectal cancer, file e2f56ed9-4e0d-3eaf-e053-3a05fe0a5d97 182
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression, file 8126a541-a33e-4b36-947c-ec40fe88ca5c 98
Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab, file e2f56eda-62d3-3eaf-e053-3a05fe0a5d97 97
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients, file e2f56eda-bd0b-3eaf-e053-3a05fe0a5d97 55
Immune Checkpoint Inhibitors in the Treatment of HCC, file e2f56eda-9def-3eaf-e053-3a05fe0a5d97 40
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment, file 4480f1a7-7551-4012-8578-67fdfd7d60d2 24
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors, file 9dd2e0c7-2148-4e4b-b971-b3f8b5a092b8 18
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment, file e2f56eda-5bf0-3eaf-e053-3a05fe0a5d97 12
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment, file 6c483200-a404-4ebf-92e7-ebf8b6a0377f 5
null, file 8d45f4b9-5957-4a43-9cec-49e03f682bec 3
Uncovering key targets of success for immunotherapy in pancreatic cancer, file e2f56eda-7532-3eaf-e053-3a05fe0a5d97 2
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis, file e8144e87-79ed-4a51-ac0d-207148126ad4 2
Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib, file 6b666e3b-0aa6-4509-8779-bc818148cedf 1
α-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma, file c9522442-3b6b-4373-b88c-be1c3ff751c8 1
Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients?, file e2f56ed8-ef7e-3eaf-e053-3a05fe0a5d97 1
BRCA-mutant pancreatic ductal adenocarcinoma, file e2f56eda-5c57-3eaf-e053-3a05fe0a5d97 1
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus, file e2f56eda-7bdd-3eaf-e053-3a05fe0a5d97 1
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast?, file e2f56eda-7cb2-3eaf-e053-3a05fe0a5d97 1
Molecular-driven treatment for biliary tract cancer: the promising turning point, file e2f56eda-924c-3eaf-e053-3a05fe0a5d97 1
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients, file e2f56eda-c45a-3eaf-e053-3a05fe0a5d97 1
Updated survival outcomes with ivosidenib in patients with previously treated IDH1-mutated intrahepatic-cholangiocarcinoma: an Italian real-world experience, file e71f0748-c441-4f5d-be21-777e6f07d7ca 1
Totale 1.574
Categoria #
all - tutte 3.724
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.724


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202026 0 0 0 0 0 0 1 0 0 2 0 23
2020/2021506 23 28 18 122 99 30 44 27 21 23 35 36
2021/2022355 21 15 27 41 41 19 26 41 18 18 52 36
2022/2023295 18 27 41 32 21 15 30 15 29 31 18 18
2023/2024392 31 32 35 32 44 61 41 54 40 22 0 0
Totale 1.574